ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1774

Granulomatosis with Polyangiitis (Wegener’s): Endoscopic Management of Tracheobronchial Stenosis – Results from a Multicenter Experience in 47 Patients

Benjamin Terrier1, Agnes Dechartres2, Charlotte Girard3, Stéphane Jouneau4, Jean-Emmanuel Kahn5, Robin Dhote6, Jean Cabane7, Estibaliz Lazaro8, Thomas Papo9, Nicolas Schleinitz10, Guillaume Le Guenno11, Luc Mouthon12 and Loïc Guillevin for the French Vasculitis Study Group12, 1National Referral Center for Rare Systemic Autoimmune Diseases, Cochin Hospital, Paris, France, 2Biostatistics, Hotel Dieu, Paris, France, 3Internal Medicine, CHU, Lyon, France, 4Pulmonology, CHU, Rennes, France, 5Internal Medicine, Foch Hospital, Suresnes, France, 6Internal Medicine, Avicenne University Hospital, Bobigny, France, 7Internal Medicine, Saint-Antoine, Paris, France, 8Centre François Magendie, CHU, Pessac, France, 9Internal Medicine, Bichat Hospital, Paris, Paris, France, 10internal medicine, APHM, marseille, France, 11Internal Medicine department, Clermont-Ferrand, France, 12National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, Paris, France

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Pulmonary Involvement and Wegener's granulomatosis

  • Tweet
  • Email
  • Print
Session Information

Title: Vasculitis

Session Type: Abstract Submissions (ACR)

Background/Purpose

Tracheobronchial stenosis (TBS) is noted in 12 to 23% in patients with granulomatosis with polyangiitis (GPA), and includes subglottic stenosis (SGS) and bronchial stenosis. The optimal systemic treatments and endoscopic interventions providing the best efficacy, and the best timing for such interventions, remain unclear, explaining why, in the 2010s, TBS remains a therapeutic challenge in the management of GPA patients.

Methods

To analyze the endoscopic management of TBS in GPA and to identify factors associated with the efficacy of endoscopic interventions, we conducted a French nationwide retrospective study that included 47 patients with GPA-related TBS. We also compared characteristics of GPA patients with TBS with GPA patients without TBS included in the French Vasculitis Study Group. 

Results

Compared to patients without TBS, those with TBS were younger, more frequently female, and had less frequent kidney, ocular and gastrointestinal involvement and mononeuritis multiplex.

173 procedures were performed in 47 patients. Endoscopic procedures included 137 tracheal and 50 bronchial interventions, mainly endoscopic dilatation, local steroid injection and conservative laser surgery, and less frequently stenting. Per-endoscopic events were noted in only 5/173 cases (2.9%). After the first endoscopic procedure, cumulative incidence of endoscopic treatment failure was 49% at 1 year, 70% at 2 years and 80% at 5 years.

Factors significantly associated with a higher cumulative incidence of treatment failure were a shorter time from GPA diagnosis to endoscopic procedure [HR 1.08 (1.01-1.14); P=0.01] and a bronchial stenosis [HR 1.96 (1.28-3.00); P=0.002]. A prednisone dose ≥30 mg/day at the time of the procedure was associated with a lower cumulative incidence of treatment failure [HR 0.53 (0.31-0.89); P=0.02]. No difference was observed according to the immunosuppressive agents used.

Finally, 13 patients (28%) experienced recurrent bacterial bronchopulmonary infections as late complications of tracheobronchial involvement, fatal in 2 cases (4%).

Conclusion

TBS represent severe and refractory manifestations with high rate of restenosis. High-dose systemic corticosteroids at the time of the procedure and increased time from GPA diagnosis to bronchoscopic intervention are associated with a better event-free survival. In contrast, bronchial stenoses are associated with a higher rate of restenosis than SGS.


Disclosure:

B. Terrier,
None;

A. Dechartres,
None;

C. Girard,
None;

S. Jouneau,
None;

J. E. Kahn,
None;

R. Dhote,
None;

J. Cabane,
None;

E. Lazaro,
None;

T. Papo,
None;

N. Schleinitz,
None;

G. Le Guenno,
None;

L. Mouthon,
None;

L. Guillevin for the French Vasculitis Study Group,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/granulomatosis-with-polyangiitis-wegeners-endoscopic-management-of-tracheobronchial-stenosis-results-from-a-multicenter-experience-in-47-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology